Annovis Bio Inc
NYSE:ANVS
Income Statement
Earnings Waterfall
Annovis Bio Inc
Revenue
|
0
USD
|
Operating Expenses
|
-45m
USD
|
Operating Income
|
-45m
USD
|
Other Expenses
|
-11.2m
USD
|
Net Income
|
-56.2m
USD
|
Income Statement
Annovis Bio Inc
Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||
Operating Expenses |
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(4)
|
(6)
|
(7)
|
(9)
|
(9)
|
(11)
|
(15)
|
(17)
|
(20)
|
(24)
|
(26)
|
(26)
|
(29)
|
(38)
|
(45)
|
|
Selling, General & Administrative |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
(3)
|
(4)
|
(4)
|
(3)
|
(4)
|
(6)
|
(8)
|
(10)
|
(10)
|
(9)
|
(8)
|
(8)
|
(6)
|
(6)
|
|
Research & Development |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(5)
|
(6)
|
(7)
|
(8)
|
(8)
|
(10)
|
(13)
|
(17)
|
(18)
|
(22)
|
(31)
|
(39)
|
|
Operating Income |
(1)
N/A
|
(1)
-1%
|
(1)
-13%
|
(1)
-12%
|
(2)
-77%
|
(2)
-25%
|
(4)
-111%
|
(6)
-32%
|
(7)
-18%
|
(9)
-40%
|
(9)
+0%
|
(11)
-13%
|
(15)
-38%
|
(17)
-14%
|
(20)
-21%
|
(24)
-18%
|
(26)
-8%
|
(26)
0%
|
(29)
-15%
|
(38)
-29%
|
(45)
-19%
|
|
Pre-Tax Income | ||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
(11)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(1)
N/A
|
(1)
-1%
|
(1)
-17%
|
(1)
-13%
|
(1)
-4%
|
(1)
-24%
|
(3)
-160%
|
(4)
-24%
|
(5)
-38%
|
(8)
-51%
|
(8)
-3%
|
(10)
-22%
|
(14)
-41%
|
(17)
-14%
|
(20)
-21%
|
(24)
-18%
|
(25)
-8%
|
(25)
+1%
|
(29)
-14%
|
(37)
-29%
|
(56)
-52%
|
|
Net Income | ||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
(4)
|
(5)
|
(8)
|
(8)
|
(10)
|
(14)
|
(17)
|
(20)
|
(24)
|
(25)
|
(25)
|
(29)
|
(37)
|
(56)
|
|
Net Income (Common) |
(1)
N/A
|
(1)
-1%
|
(1)
-17%
|
(1)
-13%
|
(1)
-4%
|
(1)
-24%
|
(3)
-160%
|
(4)
-24%
|
(5)
-38%
|
(8)
-51%
|
(8)
-3%
|
(10)
-22%
|
(14)
-41%
|
(17)
-14%
|
(20)
-21%
|
(24)
-18%
|
(25)
-8%
|
(25)
+1%
|
(29)
-14%
|
(37)
-29%
|
(56)
-52%
|
|
EPS (Diluted) |
-0.12
N/A
|
-0.12
N/A
|
-0.14
-17%
|
-0.16
-14%
|
-0.14
+13%
|
-0.26
-86%
|
-0.46
-77%
|
-0.57
-24%
|
-0.87
-53%
|
-1.2
-38%
|
-1.14
+5%
|
-1.26
-11%
|
-1.9
-51%
|
-2.02
-6%
|
-2.45
-21%
|
-2.89
-18%
|
-3.1
-7%
|
-3.09
+0%
|
-3.21
-4%
|
-4.11
-28%
|
-6.23
-52%
|